β2-microglobulin (β2M) was identified as a marker of both HAM and disease activity in a proteomic study (Kirk et al. 2011) whilst activation of T-cells has been observed in patients with HTLV-1-associated myelopathy (Ijichi et al. 1989). The gene discussed is B2M; the disease is tropical spastic paraparesis.